1. The unique transcriptional response produced by concurrent estrogen and progesterone treatment in breast cancer cells results in upregulation of growth factor pathways and switching from a Luminal A to a Basal-like subtype. Issue 1 (December 2015) Authors: Need, Eleanor; Selth, Luke; Trotta, Andrew; Leach, Damien; Giorgio, Lauren; O'Loughlin, Melissa; Smith, Eric; Gill, Peter; Ingman, Wendy; Graham, J.; Buchanan, Grant Journal: BMC cancer Issue: Volume 15:Issue 1(2015) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗